X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-04 | DRUG | Cormorant Asset Management, LP | 10% | P - Purchase | $21.70 | +184,331 | 1,059,331 | +21% | +$3,999,983 | ||||||
| M | 2024-10-15 | DRUG | Cormorant Asset Management, LP | 10% | P - Purchase | $7.65 | +422,591 | 875,000 | +93% | +$3,234,387 | |||||
| D | 2024-09-27 | BIOA | Cormorant Asset Management, LP | Former 10% Owner | P - Purchase | $18.00 | +450,000 | 1,629,529 | +38% | +$8,100,000 | |||||
2024-09-20 | CRBP | Cormorant Asset Management, LP | 10% | P - Purchase | $20.01 | +350,000 | 2,375,000 | +17% | +$7,003,761 | ||||||
2024-05-06 | EYPT | Cormorant Asset Management, LP | 10% | P - Purchase | $11.86 | +850,000 | 8,325,000 | +11% | +$10,081,721 | ||||||
2024-04-18 | EYPT | Cormorant Asset Management, LP | 10% | P - Purchase | $18.03 | +581,765 | 7,475,000 | +8% | +$10,489,446 | ||||||
2024-04-01 | IMRX | Cormorant Asset Management, LP | 10% | S - Sale | $2.90 | -400,000 | 2,895,273 | -12% | -$1,160,181 | ||||||
| M | 2024-03-14 | IMRX | Cormorant Asset Management, LP | 10% | S - Sale | $3.02 | -909,091 | 3,295,273 | -22% | -$2,749,003 | |||||
| M | 2024-03-07 | CRBP | Cormorant Asset Management, LP | 10% | P - Purchase | $42.41 | +550,000 | 2,025,000 | +37% | +$23,327,560 | |||||
2024-02-02 | CRBP | Cormorant Asset Management, LP | 10% | P - Purchase | $19.00 | +750,000 | 1,475,000 | +103% | +$14,250,000 | ||||||
2024-01-26 | CRBP | Cormorant Asset Management, LP | 10% | P - Purchase | $32.24 | +282,632 | 725,000 | +64% | +$9,111,941 | ||||||
| M | 2024-01-09 | EYPT | Cormorant Asset Management, LP | 10% | P - Purchase | $19.94 | +855,000 | 6,893,235 | +14% | +$17,051,100 | |||||
2023-12-08 | EYPT | Cormorant Asset Management, LP | 10% | P - Purchase | $17.00 | +588,235 | 6,038,235 | +11% | +$9,999,995 | ||||||
2023-12-04 | EYPT | Cormorant Asset Management, LP | 10% | P - Purchase | $21.82 | +1,919,057 | 5,450,000 | +54% | +$41,874,151 | ||||||
2023-10-23 | AMAM | Cormorant Asset Management, LP | 10% | P - Purchase | $6.99 | +1,307,311 | 11,231,000 | +13% | +$9,139,542 | ||||||
| M | 2023-09-15 | AMAM | Cormorant Asset Management, LP | 10% | P - Purchase | $9.12 | +2,152,738 | 69,465,823 | +3% | +$19,625,601 | |||||
2023-07-20 | GRNA | Cormorant Asset Management, LP | (See below) | S - Sale | $0.00 | -9,188,659 | 0 | -100% | -$0 | ||||||
| M | 2023-04-18 | AMAM | Cormorant Asset Management, LP | 10% | P - Purchase | $11.30 | +5,215,189 | 67,313,085 | +8% | +$58,950,690 | |||||
| M | 2023-04-13 | AMAM | Cormorant Asset Management, LP | 10% | P - Purchase | $9.75 | +2,597,896 | 62,097,896 | +4% | +$25,319,289 | |||||
| M | 2023-03-14 | AMAM | Cormorant Asset Management, LP | 10% | P - Purchase | $10.21 | +1,000,000 | 53,500,000 | +2% | +$10,211,400 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |